West Nile virus (WNV) is a flavivirus and NIAID Category B infectious agent that is neurotropic and causes severe encephalitis, encephalopathy, and paralysis in humans and other animals. WNV has recently emerged into the Western hemisphere and now presents a serious worldwide public health threat. WNV and other members of the flavivirus family are arboviruses and present a biothreat through their ability to disseminate, via insect vector, throughout human population centers. Importantly, pathogenic WNV shares features of host immune defense evasion with other pathogenic members of the flavivirus family, therefore serving as a platform of study to define the virus-host interactions that control WNV/flavivirus infection. Our preliminary studies have revealed that cell tropism of WNV infection, and infection outcome, are in large part controlled by the host innate immune response and the actions of type 1 interferon (IFN) that are induced during infection. We have found that WNV and other flaviviruses trigger innate antiviral immune defenses through specific pathways of pathogen recognition within infected tissues and cells, and that the resulting IFN response triggered by these pathways differs among cells to restrict the tropism of infection. Our studies show that pathogenic WNV evades innate IFN defenses by disrupting IFN signaling, suggesting that ability to suppress the host IFN response forms the basis of neurovirulence and pathogenesis among strains. Our observations define the innate host response and virus countermeasures of IFN action as key determinants controlling immunity and pathogenesis of WNV infection. We hypothesize that viral triggering and control of the host response and IFN effector actions defines the cell tropism, virulence, and outcome of WNV infection. To investigate this hypothesis, we have designed collaborative studies that embrace the strengths of the Pacific Northwest Research Center of Excellence in Biodefense. As sub-project 1 of this programproject (P01) application, we will 1) Define the cell-specific pathogen recognition pathways that induce IFN and innate defenses against WNV infection, 2) Define the IFN-stimulated effector genes that control WNV infection, tropism and spread, and 3) Determine the molecular mechanisms by which pathogenic WNV antagonizes the host cell IFN response. These studies will integrate with P01 sub-projects 2 and 3 to determine how the host kinome and flavivirus inhibitor compounds interact with host innate immune programs to control WNV and flavivirus infection. Our work will deliver new therapeutic targets and therapy applications for the treatment of WNV and flavivirus infections.

Public Health Relevance

Our investigations will utilize virologic, immunologic, biochemical, and genetic/genomic approaches within in vitro and in vivo studies to define the virus/host interface of WNV infection that controls infection outcome, and will provide novel insights to guide therapeutic and vaccine strategies aimed at modulating immunity to infection.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1-DDS-M)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Oregon Health and Science University
United States
Zip Code
Smithey, Megan J; Venturi, Vanessa; Davenport, Miles P et al. (2018) Lifelong CMV infection improves immune defense in old mice by broadening the mobilized TCR repertoire against third-party infection. Proc Natl Acad Sci U S A 115:E6817-E6825
Maurizio, Paul L; Ferris, Martin T; Keele, Gregory R et al. (2018) Bayesian Diallel Analysis Reveals Mx1-Dependent and Mx1-Independent Effects on Response to Influenza A Virus in Mice. G3 (Bethesda) 8:427-445
Uhrlaub, Jennifer L; Smithey, Megan J; Nikolich-┼Żugich, Janko (2017) Cutting Edge: The Aging Immune System Reveals the Biological Impact of Direct Antigen Presentation on CD8 T Cell Responses. J Immunol 199:403-407
Pryke, Kara M; Abraham, Jinu; Sali, Tina M et al. (2017) A Novel Agonist of the TRIF Pathway Induces a Cellular State Refractory to Replication of Zika, Chikungunya, and Dengue Viruses. MBio 8:
Gralinski, Lisa E; Ferris, Martin T; Aylor, David L et al. (2015) Genome Wide Identification of SARS-CoV Susceptibility Loci Using the Collaborative Cross. PLoS Genet 11:e1005504
Okumura, Atsushi; Rasmussen, Angela L; Halfmann, Peter et al. (2015) Suppressor of Cytokine Signaling 3 Is an Inducible Host Factor That Regulates Virus Egress during Ebola Virus Infection. J Virol 89:10399-406
LaBeaud, A Desiree; Banda, Tamara; Brichard, Julie et al. (2015) High rates of o'nyong nyong and Chikungunya virus transmission in coastal Kenya. PLoS Negl Trop Dis 9:e0003436
Mirrashidi, Kathleen M; Elwell, Cherilyn A; Verschueren, Erik et al. (2015) Global Mapping of the Inc-Human Interactome Reveals that Retromer Restricts Chlamydia Infection. Cell Host Microbe 18:109-21
Davis, Zoe H; Verschueren, Erik; Jang, Gwendolyn M et al. (2015) Global mapping of herpesvirus-host protein complexes reveals a transcription strategy for late genes. Mol Cell 57:349-60
Sali, Tina M; Pryke, Kara M; Abraham, Jinu et al. (2015) Characterization of a Novel Human-Specific STING Agonist that Elicits Antiviral Activity Against Emerging Alphaviruses. PLoS Pathog 11:e1005324

Showing the most recent 10 out of 127 publications